AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.
NEAT1, a Novel Therapeutic Target and Prognostic Biomarker for Prostate Cancer
Detailed Technology Description
This invention provides methods to treat prostate cancer usinginterfering RNA molecule targeting nuclear enriched abundant transcript 1 (NEAT1)and also methods to use NEAT1 as a biomarker for the diagnosis and prognosis ofprostate cancer.
Others
The oestrogen receptoralpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer. Nat Commun., 2014, 5, 5383. PMID:25415230.
Country/Region
USA
For more information, please click Here
